Related Experiment Video
Updated: Aug 9, 2026
Chromosome Preparation From Cultured Cells
Published on: January 28, 2014
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including
J M Bennett1, D Catovsky, M T Daniel
1University of Rochester Cancer Center, NY 14642, USA.
Abstract:
The FAB group has reviewed 32 cases of promyelocytic leukemia and variant forms. By utilizing published criteria the ability to make a correct diagnosis by morphology with molecular genetic confirmation and to eliminate cases that did not have the PML/RARalpha rearrangement was excellent.
Insights
The FAB group accurately diagnosed promyelocytic leukemia and its variants using morphology and genetic testing. This method effectively identified cases with the PML/RARalpha rearrangement, crucial for correct diagnosis.
Area of Science:
- Hematology
- Oncology
- Molecular Diagnostics
Background:
- Accurate diagnosis of promyelocytic leukemia is critical for appropriate treatment.
- Variant forms of promyelocytic leukemia can present diagnostic challenges.
Purpose of the Study:
- To evaluate the diagnostic accuracy of morphology combined with molecular genetic confirmation for promyelocytic leukemia.
- To assess the ability to identify the specific PML/RARalpha rearrangement in these cases.
Main Methods:
- Review of 32 cases of promyelocytic leukemia and variant forms by the FAB group.
- Application of established morphological criteria for initial assessment.
- Utilisation of molecular genetic testing for confirmation of the PML/RARalpha rearrangement.
Main Results:
- Excellent diagnostic accuracy was achieved using the combined morphological and molecular genetic approach.
- The study successfully identified cases with the characteristic PML/RARalpha rearrangement.
- Cases lacking the PML/RARalpha rearrangement were effectively excluded, preventing misdiagnosis.
Conclusions:
- Morphology combined with molecular genetic confirmation provides a highly reliable method for diagnosing promyelocytic leukemia.
- This integrated diagnostic strategy is essential for differentiating true promyelocytic leukemia from other conditions.
